Grantham, Mayo, Van Otterloo & Co (GMO)
AGN

Grantham, Mayo, Van Otterloo & Co (GMO)’s Allergan plc AGN Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-461,660
Closed -$81.8M – 862
2020
Q1 		$81.8M Buy
461,660
+175,129
+61% +$33M 0.68% 37
2019
Q4 		$54.8M Sell
286,531
-93,271
-25% -$16.8M 0.37% 55
2019
Q3 		$63.9M Buy
379,802
+62,962
+20% +$10.3M 0.44% 46
2019
Q2 		$53M Buy
+316,840
New +$43.9M 0.37% 58
2018
Q4 		– Sell
-15,309
Closed -$2.92M – 608
2018
Q3 		$2.92M Buy
+15,309
New +$2.81M 0.02% 265
2016
Q2 		– Sell
-188,267
Closed -$50.5M – 643
2016
Q1 		$50.5M Sell
188,267
-93,726
-33% -$26.8M 0.19% 117
2015
Q4 		$88.1M Sell
281,993
-537,691
-66% -$160M 0.32% 66
2015
Q3 		$223M Buy
819,684
+818,655
+79,558% +$251M 0.77% 28
2015
Q2 		$312K Sell
1,029
-262,590
-100% -$78.3M ﹤0.01% 411
2015
Q1 		$78.5M Buy
+263,619
New +$75.2M 0.23% 74
2014
Q2 		– Sell
-1,306
Closed -$269K – 571
2014
Q1 		$269K Sell
1,306
-16,990
-93% -$3.37M ﹤0.01% 534
2013
Q4 		$3.07M Buy
+18,296
New +$2.86M 0.01% 372

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s AGN Position: Q2 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 461,660 shares — an estimated $81.8M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AGN in Q4 2013 and held it in 12 quarters. The position peaked at $223M in Q3 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 461,660 Allergan plc shares in Q2 2020, an estimated $81.8M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Allergan plc in Q4 2013 and held it in 12 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Allergan plc position peaked at $223M in Q3 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2020, filed 13 Aug 2020.